Bank of America
MIST icon

Bank of America’s Milestone Pharmaceuticals MIST Stock Holding History

Bank of America’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-841
Closed -$1.7K – 6438
2025
Q4 		$1.7K Sell
841
-15,211
-95% -$32.8K ﹤0.01% 6422
2025
Q3 		$32.1K Buy
16,052
+16,044
+200,550% +$28.2K ﹤0.01% 6960
2025
Q2 		$16 Sell
8
-39,388
-100% -$52.5K ﹤0.01% 8263
2025
Q1 		$31.5K Buy
+39,396
New +$78.3K ﹤0.01% 6858
2023
Q4 		– Sell
-1,955
Closed -$6.06K – 8144
2023
Q3 		$6.06K Sell
1,955
-11,721
-86% -$36.4K ﹤0.01% 6950
2023
Q2 		$39K Sell
13,676
-93,813
-87% -$354K ﹤0.01% 6541
2023
Q1 		$424K Buy
107,489
+31,632
+42% +$116K ﹤0.01% 5483
2022
Q4 		$300K Buy
75,857
+3,177
+4% +$16.7K ﹤0.01% 5697
2022
Q3 		$668K Buy
+72,680
New +$551K ﹤0.01% 5174
2021
Q2 		– Sell
-37
Closed – – 7936
2021
Q1 		$0 Buy
+37
New +$271 ﹤0.01% 7635

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Bank of America's MIST Position: Q1 2026 in Review

Bank of America sold out of Milestone Pharmaceuticals (MIST) in Q1 2026, closing a stake of 841 shares — an estimated $1.7K sold.

Bank of America first reported a position in MIST in Q1 2021 and held it in 10 quarters. The position peaked at $668K in Q3 2022. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Bank of America reported no remaining Milestone Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 841 Milestone Pharmaceuticals shares in Q1 2026, an estimated $1.7K.
  • Bank of America first reported a position in Milestone Pharmaceuticals in Q1 2021 and held it in 10 quarters.
  • Bank of America's Milestone Pharmaceuticals position peaked at $668K in Q3 2022.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.